[Reaserch Advance on Bruton Tyrosine Kinase Inhibitors in the Treatment of B-Cell Tumors--Review].

Ji, Ting-Ting; Chen, Qiu-Ni; Tao, Shan-Dong; Yu, Liang

Ji, Ting-Ting; Chen, Qiu-Ni; Tao, Shan-Dong; Yu, Liang.

Afiliación

Ji TT; Department of Hematology, Huai'an First People's Hospital Affiliaed to Nanjing Medical University, Huai'an 223300, Jiangsu Province, China,Key laboratory of Hematology of Nanjing Medical University, Nanjing 210009, Jiangsu Province, China.
Chen QN; Department of Hematology, Huai'an First People's Hospital Affiliaed to Nanjing Medical University, Huai'an 223300, Jiangsu Province, China,Key laboratory of Hematology of Nanjing Medical University, Nanjing 210009, Jiangsu Province, China.
Tao SD; Department of Hematology, Huai'an First People's Hospital Affiliaed to Nanjing Medical University, Huai'an 223300, Jiangsu Province, China,Key laboratory of Hematology of Nanjing Medical University, Nanjing 210009, Jiangsu Province, China.
Yu L; Department of Hematology, Huai'an First People's Hospital Affiliaed to Nanjing Medical University, Huai'an 223300, Jiangsu Province, China,Key laboratory of Hematology of Nanjing Medical University, Nanjing 210009, Jiangsu Province, China,E-mail: yuliangha@163.com.

Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 28(1): 333-338, 2020 Feb.

Article en Zh | MEDLINE | ID: mdl-32027299

Asunto(s)

Leucemia Linfocítica Crónica de Células B; Agammaglobulinemia Tirosina Quinasa; Antineoplásicos; Linfocitos B; Humanos; Inhibidores de Proteínas Quinasas; Proteínas Tirosina Quinasas

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Límite: Humans Idioma: Zh Revista: Zhongguo Shi Yan Xue Ye Xue Za Zhi Asunto de la revista: HEMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google